2Davalos A,Fisher M.Emerging therapies for cerebrovascular disorders.Stroke,2005,34:208.
3Hoffman M,Monroe DM.The activation of high-dose factor Ⅶa in a cell-based model of hemostasis.Dis Mon,2003,49:14.
4Asif M,Siddiqui A,Lesley J.Recombinant Factor Ⅶa:A review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.Drugs,2005,65:1161.
5Hedner U,Ljundberg J,Lund-Hansen T.Comparison of the effect of plasma-derived and recombinant human FⅦa in vitro and in a rabbit model.Blood Cogul Fibrinolysis,1990,1:145.
6Veldman A,Hoffman M,Ehrenforth S.New insights into the coagulation system and implication for new therapeutic options with recombinant factor Ⅶa.Curr Med Chem,2003,10:797.
7Brott T,Broderick J,Kothari R,et al.Early hemorrhage growth in patients with intracerebral hemorrhage.Stroke,1997,28:1.
8Morgenstem LB,Demchuk AM,Kim DH,et al.Rebleeding leads to poor outcome in ultra-early craniotomy for Intracerebral hemorrhage.Neurology,2001,56:1294.
9Mendelow AD,Gregson BA,Fernandes HM,et al.Early surgeryversus initial conservative treatment in patients with spontaneous supratentorial intracerebral hematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH):a randomized trial.Lancet,2005,365:387.
10Donat R,Spahn,Michael Makris.Is recombinant FⅦa the magic bullet in the treatment of major bleeding? British Journal of Anaesthesia,2005,94:553.
